Glucose-dependent Insulinotropic Polypeptide Receptor
From Proteopedia
(Difference between revisions)
Line 61: | Line 61: | ||
* [[Hormone]] | * [[Hormone]] | ||
* [[G protein-coupled receptors|G protein-coupled receptors]] | * [[G protein-coupled receptors|G protein-coupled receptors]] | ||
+ | *[[Receptor]] | ||
+ | *[[Transmembrane (cell surface) receptors]] | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Revision as of 14:00, 3 June 2021
|
3D structures of GIPR
Updated on 03-June-2021
2qkh - GIPR + GIP - human
References
- ↑ Lynn FC, Thompson SA, Pospisilik JA, Ehses JA, Hinke SA, Pamir N, McIntosh CH, Pederson RA. A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells. FASEB J. 2003 Jan;17(1):91-3. Epub 2002 Nov 15. PMID:12475913 doi:10.1096/fj.02-0243fje
- ↑ Lynn FC, Pamir N, Ng EH, McIntosh CH, Kieffer TJ, Pederson RA. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats. Diabetes. 2001 May;50(5):1004-11. PMID:11334402
- ↑ "Byetta." BYETTA (exenatide) Injection | Welcome to BYETTA.com. Amylin Pharmaceuticals, Inc., 2011. Web. 02 Dec. 2011. <http://www.byetta.com/Pages/index.aspx>
See Also
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, David Canner, Alexander Berchansky, Logan Brushart, Wayne Decatur